### LG Hamburg stops CBD sellers The Hamburg Regional Court (LG Hamburg) has issued a ruling that significantly impacts the sale of CBD products in Germany. According to the decision, CBD products that are classified as **novel foods** under EU Regulation (EU) 2015/2283 require prior authorization from the **EFSA** before they can be marketed. Sellers who fail to comply with this requirement are violating food law regulations. #### Key points of the ruling: 1. **CBD as a novel food**: The court emphasized that CBD products, unless explicitly authorized, cannot be sold as food or food supplements within the EU. 2. **Health claims**: Any health-related claims made about CBD products must comply with the strict requirements of the **Health Claims Regulation (EC) No 1924/2006**. Unauthorized claims can lead to legal action. 3. **Consumer protection**: The ruling aligns with the **BfR** and other regulatory authorities' stance on ensuring consumer safety and transparency in the market. For further details on CBD regulations and compliance requirements, visit [Supplement-Check.eu](https://www.supplement-check.eu).